Related Experiment Video

Updated: Aug 16, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization

Kosei Ito1, Qiang Liu, Manuel Salto-Tellez

  • 1Institute of Molecular and Cell Biology, Proteos, Singapore.

Cancer Research
|September 6, 2005
PubMed

Insights

RUNX3 protein is often inactive in gastric cancer due to gene silencing or mislocalization to the cytoplasm. This impaired RUNX3 function, crucial for tumor suppression, affects 82% of gastric cancers studied.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • RUNX3 expression loss is linked to gastric cancer, often via promoter hypermethylation.
  • This study investigates other RUNX3 defects in gastric cancers that still express the gene.

Purpose of the Study:

  • To identify defects in RUNX3 properties beyond gene silencing in gastric cancer.
  • To determine the functional status of RUNX3 in gastric cancer cells.

Main Methods:

  • Immunohistochemistry was performed on 97 gastric cancer tumor specimens and 21 cell lines using anti-RUNX3 monoclonal antibodies.
  • Localization of RUNX3 protein (nuclear vs. cytoplasmic) was assessed in cancer cells.

Main Results:

  • RUNX3 was undetectable in 44% of gastric cancers and showed cytoplasmic localization in 38%, with nuclear localization in only 18%.
  • Transforming growth factor-beta is implicated in inducing RUNX3 nuclear translocation.
  • RUNX3 is inactive in the cytoplasm, and 82% of gastric cancers exhibit inactive RUNX3 due to gene silencing or cytoplasmic mislocalization.

Conclusions:

  • Gastric cancer frequently impairs RUNX3 function through gene silencing or cytoplasmic mislocalization, rendering it inactive as a tumor suppressor.
  • Mechanisms controlling RUNX3 nuclear translocation are impaired in gastric cancer, suggesting additional regulatory defects beyond gene expression.

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...